KRISTIANNE BLANKENBURG: Open Payments
NPI 1558971432 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 48 payments from 11 companies in 2025. Trend: 2023 $1,514 · 2024 $1,491 · 2025 $1,333
Food & beverage: $1,299Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $482 |
| GENZYME CORPORATION | 12 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $191 |
| Regeneron Healthcare Solutions, Inc. | 9 | $145 |
| Novartis Pharmaceuticals Corporation | 10 | $135 |
| Amgen Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, AIRSUPRA, CUVITRU, TEZSPIRE, XOLAIR, BREZTRI, Rhapsido, ADBRY.
Industry payments across TX — which companies pay providers there.
